3B Blackbio Dx Ltd.

•

kilpest.comBSE: 532067NSE: 3BBLACKBIO

Market Cap₹ 1,241 Cr.

Current Price

High / Low₹ 1,589 / 1,085

Stock P/E22.4

Book Value₹ 326

Price to Book5.16

Dividend Yield0.35 %

ROCE26.0 %

ROE19.4 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2025 • Diagnostic kits: 87.4% • Agrochemicals: 12.6%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 44.1% CAGR over last 5 years
Company is almost debt free
Company has a healthy return on capital (ROCE) of 22.5%
Company has consistently been profitable over the last 5 years
Company has delivered good sales growth of 27.3% CAGR over last 5 years

CONS

Contingent liabilities are large at 74.8% of net worth
Equity base is being diluted - shares outstanding up 14.4%
Stock is trading at 5.2x its book value
Growth is decelerating - 3Y profit CAGR (14.0%) trails the 5Y trend (44.1%)
Though reporting repeated profits, the company pays out little dividend (7.2%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareMedical Equipment/Supplies/Accessories

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	LENSKART	693.20	183.97	120568.70	0.00	2284.30	3634.35	27141.80	1332.69	12.55	21.70
2.	POLYMED	1747.55	56.22	17713.42	0.20	85.27	-8.39	525.38	30.30	14.05	24.11
3.	MOLBIO	1509.70	104.43	17397.78	0.00	527.44	—	4083.76	—	19.79	24.63
4.	3BBLACKBIO	1446.40	22.36	1241.40	0.35	8.98	-28.99	33.49	50.59	26.03	25.45
5.	LAXMIDENTL	202.65	36.10	1115.17	0.00	10.32	23.83	74.70	16.13	24.96	20.26
6.	GKB	64.59	10.04	32.56	0.00	1.85	387.99	33.04	2.26	8.82	7.97

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	14	19	18	23	19	29	25	22	22	34	50	35	33
	8	11	9	13	8	13	10	15	10	19	29	27	26
Operating Profit	6	8	9	10	11	16	15	8	12	15	22	8	7
OPM %	45.10%	40.62%	50.25%	42.96%	56.30%	55.51%	59.35%	35.20%	53.24%	43.45%	43.14%	23.96%	21.13%
	3	3	3	4	4	3	3	5	4	6	6	10	6
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	1	0	4	1
Profit before Tax	9	10	11	14	14	19	18	13	16	20	27	15	13
Tax %	21.55%	26.02%	23.68%	35.98%	21.31%	22.99%	24.16%	35.89%	20.30%	23.34%	16.39%	33.04%	32.08%
Net Profit	0	0	0	0	11	15	13	8	13	15	22	10	9
	8.41	8.86	9.94	10.26	13.19	17.35	15.75	9.38	14.76	17.55	26.19	11.44	10.48

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	17	16	23	23	29	227	81	62	74	96	153
	16	14	18	16	20	77	44	33	41	46	101
Operating Profit	2	3	5	7	9	150	37	29	33	50	52
OPM %	8.70%	15.87%	23.38%	31.02%	32.27%	66.15%	46.00%	47.08%	44.49%	51.94%	33.96%
	0	0	0	1	2	3	7	7	13	15	27
Interest	1	1	1	0	0	0	0	0	0	0	0
Depreciation	0	0	0	1	1	1	1	1	1	1	6
Profit before Tax	0	1	5	7	10	152	43	35	44	64	74
Tax %	23.35%	18.99%	24.13%	24.60%	23.52%	25.10%	25.50%	26.54%	27.59%	25.48%	24.30%
Net Profit	0	1	3	5	8	114	32	26	32	48	56
EPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	30.27	37.46	55.66	—
Dividend Payout %	0.00%	16.91%	9.32%	6.10%	6.83%	0.66%	24.43%	8.26%	8.01%	7.19%	—

COMPOUNDED SALES GROWTH

10 Years:: 18%
5 Years:: 27%
3 Years:: 6%

COMPOUNDED PROFIT GROWTH

10 Years:: 63%
5 Years:: 44%
3 Years:: 14%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: 31%
5 Years:: 42%
3 Years:: 17%
Last Year:: 19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6	6	6	6	7	7	7	9	9	9
Minority Interest	-0	0	0	0	2	16	19	3	2	3
	4	5	7	16	25	125	146	185	214	260
	8	9	6	6	4	2	3	2	1	0
Trade Payables	5	4	3	4	3	3	4	3	4	2
	1	1	7	3	4	40	14	13	18	22
Total Liabilities	24	26	30	36	45	194	192	214	248	296
	3	3	4	4	4	5	7	8	7	7
	0	0	0	0	1	59	93	92	117	156
	3	4	4	5	4	5	7	8	8	9
	0	0	0	0	0	0	0	0	36	37
Cash & Bank	0	0	2	3	9	35	29	59	62	69
	17	18	21	24	26	90	56	47	17	18
Total Assets	24	26	30	36	45	194	192	214	248	296

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	1	1	3	5	9	135	48	29	27	43
Cash from Investing	-0	-0	-1	-1	-1	-70	-28	15	-20	-34
Cash from Financing	-1	-0	0	-1	1	-2	-15	-5	-4	-3
	0	0	1	2	7	26	-6	30	3	6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	41.29	41.29	41.29	41.28	41.28	41.28	41.28	40.94	40.95
	3.28	3.27	2.68	2.49	2.70	2.64	2.57	2.57	2.50
	1.96	1.96	1.74	1.60	1.76	1.82	1.87	1.98	2.15
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	53.48	53.49	54.29	54.63	54.26	54.26	54.28	54.51	54.40

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for 3BBLACKBIO

Loading news…

🤖

AI Stock Analyst

3B Blackbio Dx Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account